Less Ads, More Data, More Tools Register for FREE

Pin to quick picksS & U Regulatory News (SUS)

Share Price Information for S & U (SUS)

Share Price is delayed by 15 minutes
Get Live Data
1,900.00    0.00 (0.00%)
Bid:
1,900.00
Ask:
1,975.00
Spread: 75.00 (3.947%)
Market Cap: £230.86m
SUS Live PriceLast checked at - London Stock Exchange

Intraday S & U Share Chart

Director/PDMR Shareholding

4 Jun 2014 16:50

RNS Number : 8717I
S & U PLC
04 June 2014
 



S & U PLC

 S & U PLC ("S&U" or "the Company")

Exercise of Options and Director/PDMR Shareholdings

S&U plc announces that it has today received due notices of exercise in respect of options granted under the Company's 2010 Long Term Incentive Plan ("LTIP"). The notices were in respect of a total of 20,000 ordinary shares of 12.5p each ("Ordinary Shares") at the exercise price of 1892 pence per share.

 

These Ordinary Shares (the "Option Shares") have been issued and allotted by the Company and rank pari passu with the Company's existing issued Ordinary Shares. The Option Shares were admitted to trading on 4 June 2014 pursuant to an existing block listing granted to the Company by London Stock Exchange plc.

 

Following the issue of these Ordinary Shares, the total number of voting rights in S&U is 11,833,425, which number should be used by shareholders and other parties subject to disclosure obligations as the denominator for the calculations by which they determine if they are required to notify their interest in or a change to their interest in the share capital of S&U under the FCA's Disclosure and Transparency rules.

 

The following Executive Directors exercised share options and sold Ordinary Shares on 4 June 2014.

 

Chris Redford exercised LTIP options over 3,500 Ordinary Shares granted in May 2011. He subsequently sold 2,500 Ordinary Shares at a price of 1892p per Ordinary Share and transferred 1,000 S&U Ordinary Shares at nil cost to his wife Tina Redford. Following these transactions, the beneficial shareholding of Chris Redford is 6,095 Ordinary Shares representing 0.05% of the total voting rights of the Company.

 

Mike Mullins exercised LTIP options over 4,000 Ordinary Shares granted in May 2011. He subsequently sold 4,000 Ordinary Shares at a price of 1892p per Ordinary Share. Following this transaction, the beneficial shareholding of Mike Mullins is nil Ordinary Shares representing 0% of the total voting rights of the Company.

 

Mike Thompson exercised LTIP options over 2,500 Ordinary Shares granted in May 2011. He subsequently sold 2,500 Ordinary Shares at a price of 1892p per Ordinary Share. Following this transaction, the beneficial shareholding of Mike Mullins is nil Ordinary Shares representing 0% of the total voting rights of the Company.

 

Guy Thompson exercised LTIP options over 7,500 Ordinary Shares granted in May 2011. He subsequently sold 7,500 of Ordinary Shares at a price of 1892p per Ordinary Share. Following this transaction, the beneficial shareholding of Guy Thompson is nil Ordinary Shares representing 0% of the total voting rights of the Company.

 

For further information, please contact: 

S&U plc www.suplc.co.uk 

Anthony Coombs, Chairman 0121 705 7777 

Broker and Financial Adviser

Adrian Trimmings Arden Partners 020 7614 5920

 

Media and Investor Relations

Will Swan Smithfield 020 7360 4900

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEZLFBZQFZBBD
Date   Source Headline
9th Apr 20217:00 amEQSEdison Investment Research Limited: S&U (SUS): Ready to meet unlocked demand
30th Mar 20217:00 amRNSPreliminary Results
18th Mar 20217:00 amRNSInvestor Presentation
11th Feb 202110:00 amRNSCORRECTION: TRADING STATEMENT & NOTICE OF RESULTS
11th Feb 20217:00 amRNSTrading Statement and Notice of Results
27th Jan 20213:40 pmRNSDirector/PDMR Shareholding
9th Dec 20204:35 pmRNSPrice Monitoring Extension
9th Dec 20207:00 amRNSTrading Statement
23rd Nov 20209:55 amRNSBlock Listing Six Monthly Return
30th Sep 20207:01 amRNSDirectorate Change
30th Sep 20207:00 amRNSInterim Results
24th Sep 20207:00 amRNSInvestor Presentation
15th Sep 20207:00 amRNSNotice of Results
28th Aug 20203:36 pmRNSHolding(s) in Company
28th Aug 20203:35 pmRNSHolding(s) in Company
11th Aug 20207:00 amRNSTRADING UPDATE AND NOTICE OF RESULTS
31st Jul 20203:06 pmRNSTotal Voting Rights
30th Jun 20205:47 pmRNSTotal Voting Rights
9th Jun 20201:10 pmRNSResult of AGM
9th Jun 20207:00 amRNSAGM Statement and Trading Update
1st Jun 202010:25 amRNSTotal Voting Rights
22nd May 20209:35 amRNSBlock Listing Six Monthly Return
13th May 202012:50 pmRNSDirector/PDMR Shareholding
6th May 20202:00 pmRNSAnnual Report and Accounts
1st May 20207:00 amRNSTotal Voting Rights
15th Apr 20204:55 pmRNSBlock Listing Application
9th Apr 20204:42 pmRNSSecond Price Monitoring Extn
9th Apr 20204:37 pmRNSPrice Monitoring Extension
8th Apr 20202:04 pmRNSPreliminary Results: Replacement
8th Apr 20207:00 amRNSPreliminary Results
6th Apr 20207:00 amRNSNotice of Results
23rd Mar 20207:00 amRNSDelay to Publication of Full Year Results
17th Mar 20204:40 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20204:41 pmRNSSecond Price Monitoring Extn
20th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20207:00 amRNSTrading Statement and Notice of Results
7th Jan 20203:19 pmRNSExercise and Sale of Options, Total Voting Rights
18th Dec 20195:40 pmRNSExercise and Sale of Options, Total Voting Rights
10th Dec 20197:00 amRNSTrading Statement
2nd Dec 20192:42 pmRNSBlock listing Six Monthly Return
23rd Oct 20193:38 pmRNSExercise and Sale of Options & Total Voting Rights
22nd Oct 20192:00 pmRNSExercise and Sale of Options & Total Voting Rights
17th Oct 20194:55 pmRNSExercise of Options and Total Voting Rights
24th Sep 20197:01 amRNSAppointment by Advantage Finance of New CEO
24th Sep 20197:00 amRNSInterim Results
15th Aug 201912:08 pmRNSSecond Price Monitoring Extn
15th Aug 201912:02 pmRNSPrice Monitoring Extension
8th Aug 20197:00 amRNSTrading Update and Notice of Results
1st Aug 20197:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.